nialamide has been researched along with Graves Disease in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicolescu-Catargi, A | 1 |
1 other study available for nialamide and Graves Disease
| Article | Year |
|---|---|
The role of the central monamine oxidase systems in the determination of EEG alterations in Graves disease.
Topics: Brain; Electroencephalography; Graves Disease; Humans; Monoamine Oxidase; Nialamide | 1969 |